Symbols / SMTI Stock $22.44 +1.45% Sanara MedTech Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
SMTI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Seth D. Yon
Exch · Country NCM · United States
Market Cap 205.64M
Enterprise Value 240.40M
Income 630.72K
Sales 107.48M
FCF (ttm) 5.84M
Book/sh 0.66
Cash/sh 1.48
Employees 108
Insider 10d —
IPO Apr 07, 1994
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 374.00
Forward P/E 41.56
PEG —
P/S 1.91
P/B 33.80
P/C —
EV/EBITDA 17.78
EV/Sales 2.24
Quick Ratio 1.99
Current Ratio 2.28
Debt/Eq 689.01
LT Debt/Eq —
EPS (ttm) 0.06
EPS next Y 0.54
EPS Growth —
Revenue Growth 18.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-12
Earnings (prior) 2026-05-12
ROA 8.27%
ROE 2.86%
ROIC —
Gross Margin 92.92%
Oper. Margin 9.52%
Profit Margin -31.24%
Shs Outstand 9.16M
Shs Float 4.74M
Insider Own 53.28%
Instit Own 16.53%
Short Float 5.06%
Short Ratio 5.20
Short Interest 268.97K
52W High 35.95
vs 52W High -37.58%
52W Low 16.05
vs 52W Low 39.81%
Beta 1.19
Impl. Vol. —
Rel Volume 0.70
Avg Volume 56.98K
Volume 39.85K
Target (mean) $34.00
Tgt Median $34.00
Tgt Low $32.00
Tgt High $36.00
# Analysts 2
Recom None
Prev Close $22.12
Price $22.44
Change 1.45%
About

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$34.00
Mean price target
2. Current target
$22.44
Latest analyst target
3. DCF / Fair value
$11.47
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$22.44
Low
$32.00
High
$36.00
Mean
$34.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-15 init Lake Street — → Buy $32
2026-01-26 reit HC Wainwright & Co. Buy → Buy $36
2025-11-14 main HC Wainwright & Co. Buy → Buy $36
2025-08-18 main HC Wainwright & Co. Buy → Buy $54
2025-05-15 main HC Wainwright & Co. Buy → Buy $53
2025-03-26 reit Cantor Fitzgerald Overweight → Overweight $46
2025-03-26 main HC Wainwright & Co. Buy → Buy $51
2025-01-23 reit Cantor Fitzgerald Overweight → Overweight $44
2025-01-23 reit HC Wainwright & Co. Buy → Buy $50
2025-01-22 reit Cantor Fitzgerald Overweight → Overweight $44
2024-12-23 init HC Wainwright & Co. — → Buy $50
2024-05-15 reit Cantor Fitzgerald Overweight → Overweight $44
2024-03-27 main Cantor Fitzgerald Overweight → Overweight $44
2024-02-06 reit Cantor Fitzgerald Overweight → Overweight $49
2023-11-15 main Cantor Fitzgerald Overweight → Overweight $49
2023-09-26 reit Cantor Fitzgerald Overweight → Overweight $59
2023-08-22 reit Cantor Fitzgerald Overweight → Overweight $59
2023-08-17 reit Cantor Fitzgerald Overweight → Overweight $59
2021-06-30 init Cantor Fitzgerald — → Overweight $45
News
RSS: Latest SMTI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 WALDROP JACOB A. Chief Operating Officer — 13,956 $0.00 $0
2026-03-20 TAYLOR ELIZABETH Chief Financial Officer — 12,687 $0.00 $0
2026-03-20 YON SETH D Chief Executive Officer — 25,430 $0.00 $0
2026-03-20 MACKEY ASHLEY M Officer — 2,804 $0.00 $0
2026-03-20 MACKEY ASHLEY M Officer — 2,804 $0.00 $0
2025-09-15 YON SETH D Chief Executive Officer — 28,563 $0.00 $0
2025-05-22 DESUTTER ROBERT ANDREW Director — 3,746 $0.00 $0
2025-05-22 MACK ROSZELL III Director — 3,433 $0.00 $0
2025-05-22 TANZBERGER ERIC D Director — 3,590 $0.00 $0
2025-05-22 MYERS KEITH G Director — 2,965 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
103.12
+18.97%
86.67
+33.36%
64.99
+41.77%
45.84
Operating Revenue
103.12
+18.97%
86.67
+33.36%
64.99
+41.77%
45.84
Cost Of Revenue
7.52
-7.60%
8.14
+3.66%
7.85
+23.45%
6.36
Reconciled Cost Of Revenue
6.24
+3.90%
6.00
-23.56%
7.85
+23.45%
6.36
Gross Profit
95.60
+21.73%
78.53
+37.45%
57.14
+44.72%
39.48
Operating Expense
86.45
+11.86%
77.29
+19.27%
64.80
+25.31%
51.71
Research And Development
5.07
+79.32%
2.83
-31.55%
4.13
+22.73%
3.37
Selling General And Administration
78.72
+9.83%
71.67
+25.75%
56.99
+23.97%
45.98
General And Administrative Expense
—
—
—
45.98
Other Gand A
—
—
—
45.98
Total Expenses
93.97
+10.00%
85.43
+17.58%
72.65
+25.10%
58.08
Operating Income
9.15
+634.95%
1.24
+116.23%
-7.67
+37.34%
-12.23
Total Operating Income As Reported
7.30
+480.26%
1.26
+129.86%
-4.22
+66.33%
-12.52
EBITDA
10.31
+68.67%
6.11
+2214.90%
-0.29
+97.50%
-11.57
Normalized EBITDA
12.14
+99.08%
6.10
+252.87%
-3.99
+61.04%
-10.24
Reconciled Depreciation
3.95
-19.85%
4.92
+33.96%
3.68
+54.99%
2.37
EBIT
6.37
+434.65%
1.19
+130.04%
-3.96
+71.56%
-13.94
Total Unusual Items
-1.83
-12764.78%
0.01
-99.61%
3.70
+379.30%
-1.33
Total Unusual Items Excluding Goodwill
-1.83
-12764.78%
0.01
-99.61%
3.70
+379.30%
-1.33
Special Income Charges
-1.83
-12764.78%
0.01
-99.58%
3.45
+1311.57%
-0.28
Impairment Of Capital Assets
1.84
0.00
—
—
Restructuring And Mergern Acquisition
0.00
+100.00%
-0.01
+99.58%
-3.45
-1311.57%
0.28
Net Income
-37.56
-288.66%
-9.66
-124.59%
-4.30
+45.79%
-7.94
Pretax Income
-0.39
+79.71%
-1.94
+56.36%
-4.44
+68.14%
-13.94
Net Non Operating Interest Income Expense
-6.76
-117.49%
-3.11
-552.91%
-0.48
0.00
Interest Expense Non Operating
6.76
+116.08%
3.13
+557.53%
0.48
0.00
Net Interest Income
-6.76
-117.49%
-3.11
-552.91%
-0.48
0.00
Interest Expense
6.76
+116.08%
3.13
+557.53%
0.48
0.00
Interest Income Non Operating
0.00
-83.29%
0.02
0.00
—
Interest Income
0.00
-83.29%
0.02
0.00
—
Other Income Expense
-2.78
-3582.90%
-0.08
-102.04%
3.70
+317.10%
-1.70
Gain On Sale Of Security
—
—
0.25
+124.13%
-1.04
Tax Provision
—
—
0.00
+100.00%
-5.84
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
+100.00%
-0.28
Net Income Including Noncontrolling Interests
-37.57
-279.02%
-9.91
-123.25%
-4.44
+45.13%
-8.09
Net Income From Continuing Operation Net Minority Interest
-0.39
+77.06%
-1.69
+60.72%
-4.30
+45.79%
-7.94
Net Income From Continuing And Discontinued Operation
-37.56
-288.66%
-9.66
-124.59%
-4.30
+45.79%
-7.94
Net Income Continuous Operations
-0.39
+79.71%
-1.94
+56.36%
-4.44
+45.13%
-8.09
Net Income Discontinuous Operations
-37.17
-366.18%
-7.97
—
—
Minority Interests
0.01
-97.80%
0.25
+80.94%
0.14
-11.71%
0.15
Normalized Income
1.44
+184.62%
-1.70
+78.70%
-8.00
-16.16%
-6.89
Net Income Common Stockholders
-37.56
-288.66%
-9.66
-124.59%
-4.30
+45.79%
-7.94
Diluted EPS
-4.36
-282.46%
-1.14
-119.23%
-0.52
+48.00%
-1.00
Basic EPS
-4.36
-282.46%
-1.14
-119.23%
-0.52
+48.00%
-1.00
Basic Average Shares
8.62
+1.64%
8.48
+2.48%
8.28
+4.71%
7.91
Diluted Average Shares
8.62
+1.64%
8.48
+2.48%
8.28
+4.71%
7.91
Diluted NI Availto Com Stockholders
-37.56
-288.66%
-9.66
-124.59%
-4.30
+45.79%
-7.94
Depreciation Amortization Depletion Income Statement
2.66
-4.45%
2.79
-24.20%
3.68
+54.99%
2.37
Depreciation And Amortization In Income Statement
2.66
-4.45%
2.79
-24.20%
3.68
+54.99%
2.37
Earnings From Equity Interest
-0.95
-958.21%
-0.09
0.00
+100.00%
-0.38
Gain On Sale Of PPE
0.01
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
72.94
-17.20%
88.09
+19.25%
73.87
+21.03%
61.04
Current Assets
33.54
+0.71%
33.31
+75.24%
19.01
-7.81%
20.62
Cash Cash Equivalents And Short Term Investments
16.58
+4.41%
15.88
+208.48%
5.15
-42.55%
8.96
Cash And Cash Equivalents
16.58
+4.41%
15.88
+208.48%
5.15
-42.55%
8.96
Cash Financial
16.58
+4.41%
15.88
+208.48%
5.15
-42.55%
8.96
Receivables
12.00
-11.46%
13.55
+58.81%
8.53
+21.83%
7.00
Accounts Receivable
12.00
-3.31%
12.41
+46.42%
8.47
+24.53%
6.81
Gross Accounts Receivable
13.37
-1.56%
13.58
+50.86%
9.00
+26.25%
7.13
Allowance For Doubtful Accounts Receivable
-1.37
-16.92%
-1.17
-122.23%
-0.53
-62.43%
-0.33
Other Receivables
—
—
0.05
-50.45%
0.10
Loans Receivable
0.00
-100.00%
1.10
0.00
—
Inventory
3.95
+43.43%
2.75
-41.64%
4.72
+32.93%
3.55
Prepaid Assets
—
—
—
—
Assets Held For Sale Current
0.07
-33.03%
0.10
—
—
Other Current Assets
0.95
-7.22%
1.02
+68.05%
0.61
-44.92%
1.10
Total Non Current Assets
39.40
-28.08%
54.79
-0.14%
54.87
+35.74%
40.42
Net PPE
2.53
+34.70%
1.88
-42.20%
3.25
+46.35%
2.22
Gross PPE
3.21
+28.79%
2.49
-44.06%
4.45
+50.17%
2.96
Accumulated Depreciation
-0.67
-10.56%
-0.61
+49.12%
-1.20
-61.64%
-0.74
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.90
+4.64%
0.86
-62.97%
2.32
+8.57%
2.14
Other Properties
2.08
+43.35%
1.45
-27.43%
2.00
+147.42%
0.81
Leases
0.23
+26.96%
0.18
+35.62%
0.13
+583.46%
0.02
Goodwill And Other Intangible Assets
22.24
-17.87%
27.08
-44.19%
48.53
+38.21%
35.11
Goodwill
3.60
+0.00%
3.60
+0.00%
3.60
+0.00%
3.60
Other Intangible Assets
18.64
-20.61%
23.48
-47.73%
44.93
+42.58%
31.51
Investments And Advances
14.63
+135.43%
6.21
+101.44%
3.08
+0.00%
3.08
Other Non Current Assets
—
19.61
—
—
Total Liabilities Net Minority Interest
67.01
+36.26%
49.18
+67.95%
29.28
+51.61%
19.32
Current Liabilities
18.63
+21.82%
15.29
+11.06%
13.77
+7.51%
12.81
Payables And Accrued Expenses
5.02
+32.34%
3.80
-6.26%
4.05
+13.39%
3.57
Payables
2.34
+52.79%
1.53
-23.54%
2.00
+40.31%
1.43
Accounts Payable
2.34
+52.79%
1.53
-23.54%
2.00
+40.31%
1.43
Current Accrued Expenses
2.68
+18.51%
2.27
+10.62%
2.05
-4.51%
2.14
Pensionand Other Post Retirement Benefit Plans Current
11.78
+16.83%
10.08
+31.37%
7.68
-1.05%
7.76
Current Debt And Capital Lease Obligation
0.35
-1.52%
0.36
-61.90%
0.94
+199.92%
0.31
Current Debt
—
—
0.58
—
Other Current Borrowings
—
—
0.58
—
Current Capital Lease Obligation
0.35
-1.52%
0.36
-0.69%
0.36
+15.05%
0.31
Other Current Liabilities
1.47
+39.75%
1.05
-4.47%
1.10
-5.41%
1.16
Total Non Current Liabilities Net Minority Interest
48.39
+42.78%
33.89
+118.43%
15.52
+138.36%
6.51
Long Term Debt And Capital Lease Obligation
47.84
+49.84%
31.93
+194.24%
10.85
+2047.39%
0.51
Long Term Debt
45.97
+49.79%
30.69
+236.76%
9.11
—
Long Term Capital Lease Obligation
1.87
+51.06%
1.24
-28.80%
1.74
+243.85%
0.51
Other Non Current Liabilities
0.55
-72.09%
1.96
-57.90%
4.66
-22.30%
6.00
Stockholders Equity
5.94
-84.93%
39.40
-12.11%
44.83
+7.18%
41.83
Common Stock Equity
5.94
-84.93%
39.40
-12.11%
44.83
+7.18%
41.83
Capital Stock
0.01
+2.22%
0.01
+2.57%
0.01
+2.83%
0.01
Common Stock
0.01
+2.22%
0.01
+2.57%
0.01
+2.83%
0.01
Share Issued
8.95
+2.21%
8.75
+2.56%
8.54
+2.83%
8.30
Ordinary Shares Number
8.95
+2.21%
8.75
+2.56%
8.54
+2.83%
8.30
Additional Paid In Capital
81.23
+5.25%
77.18
+5.93%
72.86
+11.73%
65.21
Retained Earnings
-75.30
-99.30%
-37.78
-34.77%
-28.04
-19.84%
-23.39
Minority Interest
-0.01
+98.24%
-0.49
-101.27%
-0.24
-127.10%
-0.11
Total Equity Gross Minority Interest
5.93
-84.76%
38.91
-12.73%
44.59
+6.87%
41.72
Total Capitalization
51.91
-25.94%
70.09
+29.93%
53.95
+28.97%
41.83
Working Capital
14.92
-17.21%
18.02
+243.95%
5.24
-32.93%
7.81
Invested Capital
51.91
-25.94%
70.09
+28.55%
54.53
+30.36%
41.83
Total Debt
48.19
+49.27%
32.29
+173.78%
11.79
+1339.42%
0.82
Net Debt
29.39
+98.45%
14.81
+225.78%
4.55
—
Capital Lease Obligations
2.22
+39.24%
1.60
-23.96%
2.10
+156.17%
0.82
Net Tangible Assets
-16.30
-232.33%
12.32
+433.39%
-3.70
-155.03%
6.72
Tangible Book Value
-16.30
-232.33%
12.32
+433.39%
-3.70
-155.03%
6.72
Duefrom Related Parties Current
0.00
-100.00%
0.04
+382.93%
0.01
-91.48%
0.10
Dueto Related Parties Current
—
0.03
-60.27%
0.08
+128.60%
0.03
Inventories Adjustments Allowances
-0.62
-16.70%
-0.53
-19.61%
-0.45
+14.68%
-0.52
Other Inventories
4.57
+39.09%
3.29
-36.34%
5.16
+26.80%
4.07
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
6.79
+28634.43%
-0.02
+99.27%
-3.25
+41.57%
-5.55
Cash Flow From Continuing Operating Activities
6.79
+28634.43%
-0.02
+99.27%
-3.25
+41.57%
-5.55
Net Income From Continuing Operations
-37.57
-279.02%
-9.91
-123.25%
-4.44
+45.13%
-8.09
Depreciation Amortization Depletion
3.95
-19.85%
4.92
+33.96%
3.68
+54.99%
2.37
Depreciation
—
1.03
+126.13%
0.46
+11.86%
0.41
Amortization Cash Flow
—
3.89
+20.90%
3.22
+63.95%
1.96
Depreciation And Amortization
3.95
-19.85%
4.92
+33.96%
3.68
+54.99%
2.37
Amortization Of Intangibles
—
3.89
+20.90%
3.22
+63.95%
1.96
Other Non Cash Items
4.52
+521.87%
0.73
+127.97%
-2.60
-338.53%
1.09
Stock Based Compensation
5.15
+16.20%
4.44
+28.85%
3.44
+27.38%
2.70
Asset Impairment Charge
28.82
+4515.72%
0.62
+207.70%
0.20
-27.52%
0.28
Deferred Tax
—
—
0.00
+100.00%
-5.84
Deferred Income Tax
—
—
0.00
+100.00%
-5.84
Operating Gains Losses
0.94
+947.47%
0.09
+135.85%
-0.25
-117.65%
1.42
Gain Loss On Investment Securities
—
—
-0.25
-124.13%
1.04
Gain Loss On Sale Of PPE
-0.01
0.00
0.00
-100.00%
0.00
Change In Working Capital
0.97
+206.72%
-0.91
+72.20%
-3.28
-733.53%
0.52
Change In Receivables
-0.07
+98.37%
-4.54
-162.23%
-1.73
+23.68%
-2.27
Changes In Account Receivables
-0.07
+98.37%
-4.54
-162.23%
-1.73
+23.68%
-2.27
Change In Inventory
-1.78
-223.22%
1.44
+193.36%
-1.55
-198.75%
-0.52
Change In Prepaid Assets
0.12
+123.96%
-0.52
-203.89%
0.50
+410.92%
-0.16
Change In Payables And Accrued Expense
3.23
+0.72%
3.21
+1402.81%
-0.25
-106.60%
3.73
Change In Accrued Expense
2.42
-34.17%
3.68
+547.69%
-0.82
-119.78%
4.15
Change In Payable
0.81
+271.49%
-0.47
-181.93%
0.58
+235.73%
-0.42
Change In Account Payable
0.81
+271.49%
-0.47
-181.93%
0.58
+235.73%
-0.42
Change In Other Current Liabilities
-0.53
-4.77%
-0.50
-99.27%
-0.25
+4.18%
-0.26
Investing Cash Flow
-14.97
-126.48%
-6.61
+35.23%
-10.21
-190.67%
-3.51
Cash Flow From Continuing Investing Activities
-14.97
-126.48%
-6.61
+35.23%
-10.21
-190.67%
-3.51
Net PPE Purchase And Sale
-4.57
-2117.97%
-0.21
+22.20%
-0.26
-81.90%
-0.15
Purchase Of PPE
-4.63
-2147.12%
-0.21
+22.39%
-0.27
-80.42%
-0.15
Sale Of PPE
0.06
0.00
-100.00%
0.00
-58.04%
0.00
Capital Expenditure
-4.65
-1927.52%
-0.23
+13.55%
-0.27
+64.49%
-0.75
Net Investment Purchase And Sale
-8.26
-55.81%
-5.30
0.00
+100.00%
-0.25
Purchase Of Investment
-8.26
-55.81%
-5.30
0.00
+100.00%
-0.25
Net Business Purchase And Sale
-2.12
0.00
+100.00%
-9.94
-295.16%
-2.52
Purchase Of Business
-2.12
0.00
+100.00%
-9.94
-295.16%
-2.52
Net Intangibles Purchase And Sale
-0.02
+0.00%
-0.02
0.00
+100.00%
-0.60
Purchase Of Intangibles
-0.02
+0.00%
-0.02
0.00
+100.00%
-0.60
Net Other Investing Changes
—
-1.08
—
0.00
Financing Cash Flow
8.89
-48.82%
17.37
+80.13%
9.64
+1636.81%
-0.63
Cash Flow From Continuing Financing Activities
8.89
-48.82%
17.37
+80.13%
9.64
+1636.81%
-0.63
Net Issuance Payments Of Debt
10.37
-47.05%
19.59
+102.19%
9.69
0.00
Issuance Of Debt
12.02
-59.02%
29.34
+202.83%
9.69
0.00
Repayment Of Debt
-1.65
+83.08%
-9.75
0.00
0.00
Long Term Debt Issuance
12.02
-59.02%
29.34
+202.83%
9.69
0.00
Long Term Debt Payments
-1.65
+83.08%
-9.75
0.00
—
Net Long Term Debt Issuance
10.37
-47.05%
19.59
+102.19%
9.69
0.00
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
0.00
+100.00%
-0.07
-108.23%
0.91
0.00
Proceeds From Stock Option Exercised
-0.55
-336.88%
-0.13
+7.80%
-0.14
+66.66%
-0.41
Net Other Financing Charges
-0.94
+53.67%
-2.02
-145.81%
-0.82
-274.00%
-0.22
Changes In Cash
0.70
-93.47%
10.73
+381.52%
-3.81
+60.68%
-9.69
Beginning Cash Position
15.88
+208.48%
5.15
-42.55%
8.96
-51.97%
18.65
End Cash Position
16.58
+4.41%
15.88
+208.48%
5.15
-42.55%
8.96
Free Cash Flow
2.14
+944.59%
-0.25
+92.79%
-3.51
+44.29%
-6.30
Interest Paid Supplemental Data
3.35
+112.01%
1.58
+456.79%
0.28
+137738.83%
0.00
Income Tax Paid Supplemental Data
—
—
—
—
Common Stock Issuance
—
—
0.91
0.00
Earnings Losses From Equity Investments
0.95
+958.21%
0.09
0.00
-100.00%
0.38
Issuance Of Capital Stock
—
—
0.91
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category